You have 9 free searches left this month | for more free features.

HCC

Showing 1 - 25 of 2,639

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Study of Serum Tumor Markers of HBV Associated HCC

Not yet recruiting
  • HCC
  • tumor tissue and blood tests
  • (no location specified)
Apr 10, 2023

HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • HCC
  • Liver Cirrhosis
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Carcinoma, Hepatocellular, Metabolic Syndrome Trial in Lecce (Liver resection and simultaneous sleeve gastrectomy for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • Metabolic Syndrome
  • Liver resection and simultaneous sleeve gastrectomy for HCC induced by metabolic syndrome
  • Liver resection for HCC induced by metabolic syndrome
  • Lecce, Italy
    Ospedale Vito Fazzi
Sep 23, 2023

circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

Not yet recruiting
  • Hepatic Cell Carcinoma
    • (no location specified)
    Sep 12, 2023

    A New Conception About Individualized Treatment Allocation for

    Completed
    • HCC
    • +2 more
    • TACE
    • (no location specified)
    Aug 22, 2023

    Advanced HCC, Other Solid Tumors Trial in Shanghai (KD6001, Tislelizumab, Bevacizumab)

    Not yet recruiting
    • Advanced HCC
    • Other Solid Tumors
    • Shanghai, China
      Zhongshan Hospital
    Jun 13, 2023

    Hepatocellular Carcinoma Trial in Vienna (FMT combined with Atezolizumab plus Bevacizumab)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • FMT combined with Atezolizumab plus Bevacizumab
    • Vienna, Austria
      Medical University of Vienna
    Feb 19, 2023

    Advanced HCC Trial (Lenalidomide)

    Not yet recruiting
    • Advanced HCC
    • (no location specified)
    Apr 16, 2023

    Early Diagnosis of Hepatocellular Carcinoma (HCC)

    Recruiting
    • HCC
    • +4 more
    • Biomarker dosage
    • Castellana Grotte, Bari, Italy
      RCCS "Saverio de Bellis"
    Mar 23, 2023

    EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter,

    Active, not recruiting
    • Early Hepatocellular Carcinoma
    • MWA
    • Jinan, China
      Shandong PH
    Oct 23, 2023

    17-009: Multi-Institutional Study Examining HCC Undergoing Liver

    Active, not recruiting
    • Hepatocellular Carcinoma
      • Cleveland, Ohio
      • +1 more
      Aug 29, 2023

      Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

      Recruiting
      • Liver Neoplasms
      • Tislelizumab plus tyrosine kinase inhibitor
      • Beijing, Beijing, China
        302 Hospital
      Sep 22, 2023

      Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

      Not yet recruiting
      • HCC
      • No intervention was required for patients or control group in this study
      • (no location specified)
      Apr 21, 2023

      Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • EYE90 Microspheres Treatment
      • (no location specified)
      Jul 12, 2023

      CT Perfusion Parameters for Advanced HCC Treated by Systemic

      Completed
      • Advanced HCC Treated by Systemic Immunotherapy
        • Nancy, France
          CHRU Nancy
        Oct 13, 2022

        Prognostic Models for HCC Based on Tumor Micronecrosis

        Recruiting
        • Hepatocellular Carcinoma
        • observing whether HCC patients having tumor micronecrosis
        • Hangzhou, Zhejiang, China
          the First Affiliated Hospital, School of Medicine, Zhejiang Univ
        Apr 27, 2023

        Postoperative Outcomes in Chinese HCC Patients Treated With

        Recruiting
        • Hepatocellular Carcinoma
          • Shanghai, Shanghai, China
            Zhongshan Hospital, Fudan University
          Aug 1, 2023

          Cell-free DNA From Junction of Hepatitis B Virus Integration in

          Active, not recruiting
          • Hepatocellular Carcinoma
            • Taipei, Taiwan
              National Taiwan University Hospital
            Apr 10, 2023

            Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

            Not yet recruiting
            • Hepatocellular Carcinoma
            • BCLC Stage B Hepatocellular Carcinoma
            • Atezolizumab Injection
            • +2 more
            • (no location specified)
            Mar 16, 2023

            ALBI and PALBI Scores and HCC Prognosis

            Completed
            • Hepatocellular Carcinoma (HCC) Prognosis
            • ALBI
            • Sohag, Egypt
              Sohag University
            Jan 30, 2023

            Severity of Liver Disease and Development of HCC in Cirrhotic

            Not yet recruiting
            • HCC
              • (no location specified)
              Jul 22, 2022

              Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

              Not yet recruiting
              • Liver Cancer
              • Stereotactic Body Radiation Treatment
              • Kansas City, Kansas
                University of Kansas Medical Center
              Feb 13, 2023

              Hepatocellular Carcinoma (HCC) Trial in Beijing (¹³C-Octanoate Breath Test)

              Completed
              • Hepatocellular Carcinoma (HCC)
              • ¹³C-Octanoate Breath Test
              • Beijing, China
              • +1 more
              Dec 19, 2022

              Hepatocellular Carcinoma, Surgery Trial (Autotransfusion)

              Not yet recruiting
              • Hepatocellular Carcinoma
              • Surgery
              • Autotransfusion
              • (no location specified)
              Nov 9, 2022

              Hepatectomy for Early-stage HCC Patients With CSPH

              Completed
              • HCC
              • Portal Hypertension
              • hepatectomy
              • (no location specified)
              May 30, 2022